Alon Ben-Noon (@noonalon) 's Twitter Profile
Alon Ben-Noon

@noonalon

Leading NeuroSense Therapeutics (Nasdaq: $NRSN), a Clinical stage Biotech company, accelerating therapies for ALS and Neurodegenerative diseases.

ID: 1213345396023390208

linkhttps://www.neurosense-tx.com/ calendar_today04-01-2020 06:24:32

284 Tweet

1,1K Followers

2,2K Following

Alon Ben-Noon (@noonalon) 's Twitter Profile Photo
Alon Ben-Noon
@noonalon

6 months ago

$NRSN I thank Prof. Jeremy Shefner for his continued support. He states, "The latest results from the PARADIGM study are incredibly encouraging and provide compelling evidence of PrimeC's potential to significantly benefit people living with ALS. The substantial improvement in